Justification of 150 mg clopidogrel in patients with high on-clopidogrel platelet reactivity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Justification of 150 mg clopidogrel in patients with high on-clopidogrel platelet reactivity

Published:2011-09-09 Issue:4 Volume:42 Page:384-392
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Aradi Dániel,Rideg Orsolya,Vorobcsuk András,Magyarlaki Tamás,Magyari Balázs,Kónyi Attila,Pintér Tünde,Horváth Iván G.,Komócsi András

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2362.2011.02594.x/fullpdf

Reference26 articles.

1. Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial;Steinhubl;JAMA,2002

2. Impact of genetic variants on post-clopidogrel platelet reactivity in patients after elective percutaneous coronary intervention;Rideg;Pharmacogenomics,2011

3. Platelet function monitoring in patients on clopidogrel;Aradi;Interv Med Appl Sci,2011

4. Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis;Aradi;Am Heart J,2010

5. Acceptance of high platelet reactivity as a risk factor: now, what do we do about it?;Gurbel;JACC Cardiovasc Interv,2010

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Strategies to Guide the Antiplatelet Therapy in Acute Coronary Syndromes;International Journal of Molecular Sciences;2024-04-03

2. Platelets and the Atherosclerotic Process: An Overview of New Markers of Platelet Activation and Reactivity, and Their Implications in Primary and Secondary Prevention;Journal of Clinical Medicine;2023-09-20

3. Clinical Outcomes of Individualized Antiplatelet Therapy Based on Platelet Function Test in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis;Journal of Cardiovascular Pharmacology;2023-04

4. Genotype-Guided Use of P2Y12 Inhibitors: A Review of Current State of the Art;Frontiers in Cardiovascular Medicine;2022-03-23

5. Platelet Function Testing and Genotyping for Tailoring Treatment in Complex PCI Patients;US Cardiology Review;2021-08-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3